Effect of cinnamon supplement on multiple sclerosis patients
Phase 3
- Conditions
- multiple sclerosis.Multiple sclerosis
- Registration Number
- IRCT201312024610N2
- Lead Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Including criteria’s: proved MS disease according to clinical examination and disease history; Expanded Disability Status Scale (EDSS) score 2 – 5.5; had a regular drug therapy and no change in drugs for last 4 weeks.
Excluding criteria’s: history of drug or alcohol abuse, pregnancy or lactation during the last 12 months, renal or liver failure; and steroid therapy during last two months; another neurologic disease except MS; cardiovascular disease; or infection and sensitivity to cinnamon.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fatigue. Timepoint: 1 month. Method of measurement: questionnarie.
- Secondary Outcome Measures
Name Time Method Quality of life. Timepoint: 1 month. Method of measurement: questionnaire.